Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Diagnostic device for detecting state of non-alcoholic fatty liver disease

A fatty liver disease, non-alcoholic technology, applied in measuring devices, medical automated diagnosis, biological testing, etc., can solve the problems of no accurate diagnostic methods available, and achieve fast and comprehensive evaluation and diagnosis, technical solutions and clear effects Effect

Active Publication Date: 2021-04-27
HUMAN METABOLOMICS INST INC
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009]There is currently no such precise diagnostic method available for all stages of NASH

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Diagnostic device for detecting state of non-alcoholic fatty liver disease
  • Diagnostic device for detecting state of non-alcoholic fatty liver disease
  • Diagnostic device for detecting state of non-alcoholic fatty liver disease

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0084] Example 1 Research sample

[0085] The relevant experimental samples and methods of the present invention are as follows:

[0086] (1) Clinical samples

[0087] The clinical trial is a multi-center experiment, and the test samples in the present invention have been approved by the local ethics committee and the informed consent of all subjects has been obtained. Liver samples were obtained from adult patients who underwent liver biopsy and met clinical diagnostic criteria such as NAFLD, NASH; all subjects with the following conditions were excluded from the study: history of alcohol consumption, cancer, diabetes, or any other disease related to the liver. Peripheral venous blood samples were drawn after these subjects had fasted overnight for 12 hours.

[0088] According to the study protocol, the following analyzes were performed on all samples:

[0089] Hematology includes hemoglobin, hematocrit, RBC count, white blood cells, differential white blood cell count (ne...

Embodiment 2

[0102] Example 2 Establishment of Clinical Index Diagnosis Model

[0103] Use 70% of the training set data as the screening algorithm training, and 30% of the training set data as the algorithm test evaluation. In order to fully and reasonably compare the classification performance of the algorithm, the training data is randomly divided 100 times according to 7:3, and the decision tree (DT), random forest (RF), and gradient boosting tree (GBDT, here referred to as the GB model) are used to model 100 times. See the flow chart of prediction and algorithm training figure 1 .

[0104] Evaluation indicators and methods: You can choose the size of the area under the receiver operating characteristic curve (AUROC) as a judgment indicator to measure the classification performance of the classifier, and select the AUROC with the largest prediction and the largest average value of 100 predictions among the four algorithm models Design algorithms for optimal models.

[0105] The inve...

Embodiment 3

[0106] Example 3 Differentiate non-alcoholic simple fatty liver disease

[0107] Using a machine learning algorithm to establish a diagnostic model using clinical samples to evaluate hepatic steatosis, the gradient boosting tree model trained in the training set, preferably, can be analyzed by analyzing the subject's age, body mass index, fasting blood glucose, and gamma-glutamyl transfer Enzyme, high-density lipoprotein cholesterol, total bilirubin, albumin, aspartate aminotransferase, and platelet count nine clinical indicators, which output the possibility of subjects suffering from non-alcoholic simple fatty liver disease, That is to distinguish non-fatty liver (S0), mild fatty liver (S1), moderate fatty liver (S2) and severe fatty liver (S3), and find the best cut-off value through the Youden optimal point in ROC analysis, and diagnose no fatty liver. The cut-off value of fatty liver S0 and fatty liver patients is 2.63; the cut-off value of distinguishing non-fatty liver ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Sensitivityaaaaaaaaaa
Login to View More

Abstract

The invention provides a diagnostic device for detecting a non-alcoholic fatty liver disease state of a test subject. According to the diagnostic device, the age and weight index of a subject, fasting blood glucose of a biological sample of the subject, gamma-glutamyltransferase, high-density lipoprotein, cholesterol, total bilirubin, albumin, aspartate aminotransferase and platelet count are taken as diagnosis indexes; and the non-alcoholic fatty liver disease state of the subject can be evaluated by combining the biomarker level of the biological sample of the subject. The diagnosis device disclosed by the invention can be used for quickly, accurately and comprehensively evaluating and diagnosing the non-alcoholic fatty liver disease state of the test body.

Description

technical field [0001] The invention belongs to the technical field of biological detection, and specifically relates to a diagnostic device for detecting the state of nonalcoholic fatty liver disease. Diagnosis and grading of fatty liver disease. The invention also relates to a method for monitoring the therapeutic effect of the nonalcoholic fatty liver disease and the evaluation method of the therapeutic drug. Background technique [0002] Fatty liver refers to the lesion of excessive fat accumulation in liver cells caused by various reasons. It is a common pathological change of the liver, rather than an independent disease. Fatty liver disease is seriously threatening the health of the Chinese people, becoming the second largest liver disease after viral hepatitis, the incidence rate is constantly increasing, and the age of onset is getting younger. Normal human liver tissue contains a small amount of fat, such as triglycerides, phospholipids, glycolipids, and choleste...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): G16H50/20G16H70/40G01N33/50G01N33/573G01N33/68G01N33/92
CPCG16H50/20G16H70/40G01N33/68G01N33/573G01N33/92G01N33/50Y02A90/10
Inventor 贾伟谢国祥陈天璐周科军
Owner HUMAN METABOLOMICS INST INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com